Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: classes discovered from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020;38:1–9.
Huang AT, Garcia-Carreras B, Hitchings MDT, Yang B, Katzelnick L, Rattigan SM, et al. A scientific evaluation of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of safety, and affiliation of antibody responses with severity of illness, Infectious Ailments (besides HIV/AIDS). 2020.
Melgaco JG, Azamor T, Ano Bom APD. Protecting immunity after COVID-19 has been questioned: what can we do with out SARS-CoV-2-IgG detection? Cell Immunol. 2020;353: 104114.
Wu F, Wang A, Liu M, Wang Q, Chen J, Xia S, et al. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered affected person cohort and their implications, Infectious Ailments (besides HIV/AIDS). 2020.
Thevarajan I, Nguyen TH, Koutsakos M, Druce J, Caly L, van de Sandt CE, et al. Breadth of concomitant immune responses underpinning viral clearance and affected person restoration in a non-severe case of COVID-19, Infectious Ailments (besides HIV/AIDS). 2020.
Weiskopf D, Schmitz KS, Raadsen MP, Grifoni A, Okba NMA, Endeman H, et al. Phenotype of SARS-CoV-2-specific T-cells in COVID-19 sufferers with acute respiratory misery syndrome, Infectious Ailments (besides HIV/AIDS). 2020.
Bauer T, Jilg W. Hepatitis B floor antigen-specific T and B cell reminiscence in people who had misplaced protecting antibodies after hepatitis B vaccination. Vaccine. 2006;24:572–7.
Neutra MR, Kozlowski PA. Mucosal vaccines: the promise and the problem. Nat Rev Immunol. 2006;6:148–58.
Moreno-Fierros L, Garcia-Silva I, Rosales-Mendoza S. Improvement of SARS-CoV-2 vaccines: ought to we give attention to mucosal immunity? Skilled Opin Biol Ther. 2020;20:831.
Bacon A, Makin J, Sizer PJ, Jabbal-Gill I, Hinchcliffe M, Illum L, et al. Carbohydrate biopolymers improve antibody responses to mucosally delivered vaccine antigens. Infect Immun. 2000;68:5764–70.
Bertram U, Bernard MC, Haensler J, Maincent P, Bodmeier R. In situ gelling nasal inserts for influenza vaccine supply. Drug Dev Ind Pharm. 2010;36:581–93.
Dhakal S, Cheng X, Salcido J, Renu S, Bondra Ok, Lakshmanappa YS, et al. Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protecting immune response in pigs. Int J Nanomedicine. 2018;13:6699–715.
Woodrow KA, Bennett KM, Lo DD. Mucosal vaccine design and supply. Annu Rev Biomed Eng. 2012;14:17–46.
Heit A, Schmitz F, Haas T, Busch DH, Wagner H. Antigen co-encapsulated with adjuvants effectively drive protecting T cell immunity. Eur J Immunol. 2007;37:2063–74.
Schliehe C, Redaelli C, Engelhardt S, Fehlings M, Mueller M, van Rooijen N, et al. CD8- dendritic cells and macrophages cross-present poly(D, L-lactate-co-glycolate) acid microsphere-encapsulated antigen in vivo. J Immunol. 2011;187:2112–21.
Foged C, Brodin B, Frokjaer S, Sundblad A. Particle dimension and floor cost have an effect on particle uptake by human dendritic cells in an in vitro mannequin. Int J Pharm. 2005;298:315–22.
Dhakal S, Hiremath J, Bondra Ok, Lakshmanappa YS, Shyu DL, Ouyang Ok, et al. Biodegradable nanoparticle supply of inactivated swine influenza virus vaccine gives heterologous cell-mediated immune response in pigs. J Management Launch. 2017;247:194–205.
Hiremath J, Kang KI, Xia M, Elaish M, Binjawadagi B, Ouyang Ok, et al. Entrapment of H1N1 influenza virus derived conserved peptides in PLGA nanoparticles enhances T cell response and vaccine efficacy in pigs. PLoS ONE. 2016;11: e0151922.
Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Preat V. PLGA-based nanoparticles: an outline of biomedical functions. J Management Launch. 2012;161:505–22.
Zhang F, Peng B, Chang H, Zhang R, Lu F, Wang F, et al. Intranasal immunization of mice to keep away from interference of maternal antibody in opposition to H5N1 an infection. PLoS ONE. 2016;11: e0157041.
Renu S, Feliciano-Ruiz N, Patil V, Schrock J, Han Y, Ramesh A, et al. Immunity and protecting efficacy of mannose conjugated chitosan-based influenza nanovaccine in maternal antibody optimistic pigs. Entrance Immunol. 2021;12: 584299.
Kanekiyo M, Wei CJ, Yassine HM, McTamney PM, Boyington JC, Whittle JR, et al. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature. 2013;499:102–6.
Du Y, Xu Y, Feng J, Hu L, Zhang Y, Zhang B, et al. Intranasal administration of a recombinant RBD vaccine induced protecting immunity in opposition to SARS-CoV-2 in mouse. Vaccine. 2021;39:2280–7.
Huang WC, Chiem Ok, Martinez-Sobrido L, Lovell JF. Intranasal immunization with liposome-displayed receptor-binding area induces mucosal immunity and safety in opposition to SARS-CoV-2. Pathogens. 2022;11:1035.
Lovell JF, Baik YO, Choi SK, Lee C, Lee JY, Miura Ok, et al. Interim evaluation from a part 2 randomized trial of EuCorVac-19: a recombinant protein SARS-CoV-2 RBD nanoliposome vaccine. BMC Med. 2022;20:462.
Dhakal S, Renu S, Ghimire S, Shaan Lakshmanappa Y, Hogshead BT, Feliciano-Ruiz N, et al. Mucosal immunity and protecting efficacy of intranasal inactivated influenza vaccine is improved by chitosan nanoparticle supply in pigs. Entrance Immunol. 2018;9:934.
Malyala P, Chesko J, Ugozzoli M, Goodsell A, Zhou F, Vajdy M, et al. The efficiency of the adjuvant, CpG oligos, is enhanced by encapsulation in PLG microparticles. J Pharm Sci. 2008;97:1155–64.
Bolhassani A, Safaiyan S, Rafati S. Enchancment of various vaccine supply techniques for most cancers remedy. Mol Most cancers. 2011;10:3.
Renukaradhya GJ, Meng XJ, Calvert JG, Roof M, Lager KM. Inactivated and subunit vaccines in opposition to porcine reproductive and respiratory syndrome: present standing and future route. Vaccine. 2015;33:3065–72.
Moon JJ, Suh H, Li AV, Ockenhouse CF, Yadava A, Irvine DJ. Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that broaden Tfh cells and promote germinal middle induction. Proc Natl Acad Sci U S A. 2012;109:1080–5.
Binjawadagi B, Dwivedi V, Manickam C, Ouyang Ok, Torrelles JB, Renukaradhya GJ. An revolutionary strategy to induce cross-protective immunity in opposition to porcine reproductive and respiratory syndrome virus within the lungs of pigs by adjuvanted nanotechnology-based vaccination. Int J Nanomed. 2014;9:1519–35.
Binjawadagi B, Dwivedi V, Manickam C, Ouyang Ok, Wu Y, Lee LJ, et al. Adjuvanted poly(lactic-co-glycolic) acid nanoparticle-entrapped inactivated porcine reproductive and respiratory syndrome virus vaccine elicits cross-protective immune response in pigs. Int J Nanomed. 2014;9:679–94.
Pulendran B, Ahmed R. Translating innate immunity into immunological reminiscence: implications for vaccine growth. Cell. 2006;124:849–63.
Kawai T, Akira S. The function of pattern-recognition receptors in innate immunity: replace on Toll-like receptors. Nat Immunol. 2010;11:373–84.
Salman HH, Irache JM, Gamazo C. Immunoadjuvant capability of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination. Vaccine. 2009;27:4784–90.
Braga TT, Forni MF, Correa-Costa M, Ramos RN, Barbuto JA, Branco P, et al. Soluble uric acid prompts the NLRP3 inflammasome. Sci Rep. 2017;7:39884.
Ng G, Chau EM, Shi Y. Current developments in immune activation by uric acid crystals. Arch Immunol Ther Exp. 2010;58:273–7.
Sakamaki I, Inai Ok, Tsutani H. Security of intradermal injection of monosodium urate crystals as a vaccine provider in volunteers. Nucleosides Nucleotides Nucleic Acids. 2011;30:1077–84.
Cheng XG, Zhong GM, Mcdonough J, MacNaughton M. In vivo analysis of MSU crystals as an adjuvant. Vaccine Improvement Heart of San Antonio Convention, Nov 13–14, 20142014.
Kim YI, Kim SG, Kim SM, Kim EH, Park SJ, Yu KM, et al. An infection and fast transmission of SARS-CoV-2 in ferrets. Cell Host Microbe. 2020;27:704–9.
Topol EJ, Iwasaki A. Operation nasal vaccine-lightning pace to counter COVID-19. Sci Immunol. 2022;7: eadd9947.
Sheikh-Mohamed S, Isho B, Chao GYC, Zuo M, Cohen C, Lustig Y, et al. Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are related to safety in opposition to subsequent an infection. Mucosal Immunol. 2022;15:799–808.
Mistry P, Barmania F, Mellet J, Peta Ok, Strydom A, Viljoen IM, et al. SARS-CoV-2 variants, vaccines, and host immunity. Entrance Immunol. 2021;12: 809244.
Park JW, Lagniton PNP, Liu Y, Xu RH. mRNA vaccines for COVID-19: what, why and the way. Int J Biol Sci. 2021;17:1446–60.
Naaber P, Tserel L, Kangro Ok, Sepp E, Jurjenson V, Adamson A, et al. Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal potential examine. Lancet Reg Well being Eur. 2021;10: 100208.
Wang Z, Schmidt F, Weisblum Y, Muecksch F, Barnes CO, Finkin S, et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature. 2021;592:616–22.
Manocha M, Pal PC, Chitralekha KT, Thomas BE, Tripathi V, Gupta SD, et al. Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles together with Ulex Europaeus-I lectin as M cell goal. Vaccine. 2005;23:5599–617.
Lisa Schnirring CN, Feb 21, 2018. CDC vaccine panel brings again FluMist for 2018–19 season. http://www.cidrapumnedu/news-perspective/2018/02/cdc-vaccine-panel-brings-back-flumist-2018-19-season. 2018.
Mazanec MB, Coudret CL, Fletcher DR. Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J Virol. 1995;69:1339–43.
Suzuki T, Kawaguchi A, Ainai A, Tamura S, Ito R, Multihartina P, et al. Relationship of the quaternary construction of human secretory IgA to neutralization of influenza virus. Proc Natl Acad Sci USA. 2015;112:7809–14.
Shim BS, Park SM, Quan JS, Jere D, Chu H, Track MK, et al. Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus/polyethylenimine nanoparticles elicits antigen-specific humoral and mobile immune responses. BMC Immunol. 2010;11:65.
Du L, Zhao G, Lin Y, Sui H, Chan C, Ma S, et al. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding area of extreme acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces robust mucosal immune responses and gives long-term safety in opposition to SARS-CoV an infection. J Immunol. 2008;180:948–56.
Hu MC, Jones T, Kenney RT, Barnard DL, Burt DS, Lowell GH. Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and safety in mice. Vaccine. 2007;25:6334–40.
Kamijuku H, Nagata Y, Jiang X, Ichinohe T, Tashiro T, Mori Ok, et al. Mechanism of NKT cell activation by intranasal coadministration of alpha-galactosylceramide, which may induce cross-protection in opposition to influenza viruses. Mucosal Immunol. 2008;1:208–18.
Guillonneau C, Mintern JD, Hubert FX, Damage AC, Besra GS, Porcelli S, et al. Mixed NKT cell activation and influenza virus vaccination boosts reminiscence CTL technology and protecting immunity. Proc Natl Acad Sci USA. 2009;106:3330–5.
Dormitzer PR, Galli G, Castellino F, Golding H, Khurana S, Del Giudice G, et al. Influenza vaccine immunology. Immunol Rev. 2011;239:167–77.
Eickhoff CS, Blazevic A, Killoran EA, Morris MS, Hoft DF. Induction of mycobacterial protecting immunity by sublingual BCG vaccination. Vaccine. 2019;37:5364–70.
Gallorini S, Taccone M, Bonci A, Nardelli F, Casini D, Bonificio A, et al. Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but additionally induces native IgA and TH17 responses. Vaccine. 2014;32:2382–8.
Karolewicz B. A evaluation of polymers as multifunctional excipients in drug dosage kind know-how. Saudi Pharm J. 2016;24:525–36.
Piskin E. Biodegradable polymers as biomaterials. J Biomater Sci Polym Ed. 1995;6:775–95.
Piskin E. Biodegradable polymers in drugs. In: Scott G, editor. Degradable polymers. Dordrecht: Springer; 2002.
Merchandise FsRSPfGPP-BD. https://www.americanpharmaceuticalreview.com/Featured-Articles/188841-FDA-s-Regulatory-Science-Program-for-Generic-PLA-PLGA-Primarily based-Drug-Merchandise/. 2016.
Makadia HK, Siegel SJ. Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable managed drug supply provider. Polymers. 2011;3:1377–97.
Menon JU, Ravikumar P, Pise A, Gyawali D, Hsia CC, Nguyen KT. Polymeric nanoparticles for pulmonary protein and DNA supply. Acta Biomater. 2014;10:2643–52.
Khatri M, Dwivedi V, Krakowka S, Manickam C, Ali A, Wang L, et al. Swine influenza H1N1 virus induces acute inflammatory immune responses in pig lungs: a possible animal mannequin for human H1N1 influenza virus. J Virol. 2010;84:11210–8.
Dhakal S, Goodman J, Bondra Ok, Lakshmanappa YS, Hiremath J, Shyu DL, et al. Polyanhydride nanovaccine in opposition to swine influenza virus in pigs. Vaccine. 2017;35:1124.
Renu S, Feliciano-Ruiz N, Ghimire S, Han Y, Schrock J, Dhakal S, et al. Poly(I:C) augments inactivated influenza virus-chitosan nanovaccine induced cell mediated immune response in pigs vaccinated intranasally. Vet Microbiol. 2020;242: 108611.
Dhakal S, Renukaradhya GJ. Nanoparticle-based vaccine growth and analysis in opposition to viral infections in pigs. Vet Res. 2019;50:90.
Dhakal S, Ghimire S, Renu S, Ross KA, Lakshmanappa YS, Hogshead BT, et al. Analysis of CpG-ODN-adjuvanted polyanhydride-based intranasal influenza nanovaccine in pigs. Vet Microbiol. 2019;237: 108401.
Renu S, Dhakal S, Kim E, Goodman J, Lakshmanappa YS, Wannemuehler MJ, et al. Intranasal supply of influenza antigen by nanoparticles, however not NKT-cell adjuvant differentially induces the expression of B-cell activation elements in mice and swine. Cell Immunol. 2018;329:27–30.
Risma KA, Edwards KM, Hummell DS, Little FF, Norton AE, Stallings A, et al. Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines. J Allergy Clin Immunol. 2021;147:2075–82.
Forgacs D, Jang H, Abreu RB, Hanley HB, Gattiker JL, Jefferson AM, et al. SARS-CoV-2 mRNA vaccines elicit totally different responses in immunologically naive and pre-immune people. Entrance Immunol. 2021;12: 728021.
Bergamaschi C, Terpos E, Rosati M, Angel M, Bear J, Stellas D, et al. Systemic IL-15, IFN-gamma, and IP-10/CXCL10 signature related to efficient immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients. Cell Rep. 2021;36: 109504.
Peng P, Deng H, Li Z, Chen Y, Fang L, Hu J, et al. Distinct immune responses within the early part to pure SARS-CoV-2 an infection or vaccination. J Med Virol. 2022;94:5691–701.
Wang X, Zhang Y, Amberson A, Engelhardt JF. New fashions of the tracheal airway outline the glandular contribution to airway floor fluid and electrolyte composition. Am J Respir Cell Mol Biol. 2001;24:195–202.
Liu X, Driskell RR, Engelhardt JF. Airway glandular growth and stem cells. Curr High Dev Biol. 2004;64:33–56.
Liu X, Luo M, Zhang L, Ding W, Yan Z, Engelhardt JF. Bioelectric properties of chloride channels in human, pig, ferret, and mouse airway epithelia. Am J Respir Cell Mol Biol. 2007;36:313–23.
Frere JJ, Serafini RA, Pryce KD, Zazhytska M, Oishi Ok, Golynker I, et al. SARS-CoV-2 an infection in hamsters and people leads to lasting and distinctive systemic perturbations put up restoration. Sci Transl Med. 2022;229: eabq3059.
Studier FW. Protein manufacturing by auto-induction in excessive density shaking cultures. Protein Expr Purif. 2005;41:207–34.
Cheng X, Tsao C, Saul JM, Sylvia V, Cornet D, Christy R. Comparability of two nanoparticle formulations for localized supply of platelet-derived development issue (PDGF) from aligned collagen fibers. Pharm Nanotechnol. 2013;1:105–14.
Cheng X, Carson Ok, Mcdonough J, Gourapura RG, Lee CW, Dhakal S. A liposomal subunit flu vaccine formulation. US Patent software (pending), SwRI invention disclosure docket # 3928 2017.
Fry DW, White JC, Goldman ID. Speedy separation of low molecular weight solutes from liposomes with out dilution. Anal Biochem. 1978;90:809–15.
Cheng X, Haggins DG, York RH, Yeni YN, Akkus O. Evaluation of crystals resulting in joint arthropathies by Raman spectroscopy: comparability with compensated polarized imaging. Appl Spectrosc. 2009;63:381–6.
Ramakrishnan MA. Dedication of fifty% endpoint titer utilizing a easy components. World J Virol. 2016;5:85–6.
Carolan LA, Butler J, Rockman S, Guarnaccia T, Damage AC, Studying P, et al. TaqMan actual time RT-PCR assays for detecting ferret innate and adaptive immune responses. J Virol Strategies. 2014;205:38–52.
Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP. Dedication of secure housekeeping genes, differentially regulated goal genes and pattern integrity: BestKeeper–Excel-based instrument utilizing pair-wise correlations. Biotechnol Lett. 2004;26:509–15.
Livak KJ, Schmittgen TD. Evaluation of relative gene expression knowledge utilizing real-time quantitative PCR and the two(-Delta Delta C(T)) Technique. Strategies. 2001;25:402–8.
